☆ 4.7 Article

Influence of Different Types of β-Blockers on Mortality in Patients on Hemodialysis

BIOMEDICINES (2023)

Related references

Note: Only part of the references are listed.

Review Multidisciplinary Sciences

Impact of type of dialyzable beta-blockers on subsequent risk of mortality in patients receiving dialysis: A systematic review and meta-analysis

Tzu-Hsuan Yeh et al.

Summary: This study aimed to compare the outcomes of patients receiving dialyzable beta-blockers (DBBs) and non-dialyzable beta-blockers (NDBBs). The results showed that both types of beta-blockers had no impact on the risk of all-cause mortality, overall major adverse cardiac events (MACE), and acute myocardial infarction (AMI) among dialysis patients. However, DBBs were associated with a significant reduction in the risk of heart failure compared to NDBBs.

PLOS ONE (2022)

Add to Collection

Review Multidisciplinary Sciences

Cardio-selective versus non-selective β-blockers for cardiovascular events and mortality in long-term dialysis patients: A systematic review and meta-analysis

Shaohua Tao et al.

Summary: The purpose of this systematic review is to examine whether there are differences in cardiovascular events and all-cause mortality between dialysis patients receiving cardio-selective and non-selective agents. The study results showed that cardio-selective beta-blockers are probably associated with fewer cardiovascular events and may have lower all-cause mortality in long-term dialysis patients than non-selective beta-blockers.

PLOS ONE (2022)

Add to Collection

Review Urology & Nephrology

?-Blocker Use and Cardiovascular Outcomes in Hemodialysis: A Systematic Review

Abhinav Tella et al.

Summary: This systematic review examined the use of different dialyzability beta-blockers in dialysis patients. The study found that highly dialyzable beta-blockers were associated with fewer cardiovascular events compared to poorly dialyzable beta-blockers in dialysis patients, without a significant impact on mortality.

KIDNEY MEDICINE (2022)

Add to Collection

Article Urology & Nephrology

Clinical significance of hemodialysis quality of care indicators in very elderly patients with end stage kidney disease

Hyung Woo Kim et al.

Summary: This study investigated the association between hemodialysis quality indicators and major adverse cardiovascular and cerebrovascular events (MACCE) in very elderly patients. The results showed that indicators related to the quality of hemodialysis were associated with MACCE and all-cause mortality risk in patients aged < 80 years, but not in patients aged >= 80 years. However, low serum albumin levels were associated with poor outcomes regardless of patient age.

JOURNAL OF NEPHROLOGY (2022)

Add to Collection

Article Urology & Nephrology

Comparative effectiveness of bisoprolol and carvedilol among patients receiving maintenance hemodialysis

Ping-Hsun Wu et al.

Summary: This study compared the health outcomes associated with the two most commonly used beta-blockers, carvedilol and bisoprolol, in patients undergoing hemodialysis, finding that bisoprolol initiation was associated with a lower 2-year risk of death and major adverse cardiovascular events, mainly due to lower risks of heart failure and ischemic stroke.

CLINICAL KIDNEY JOURNAL (2021)

Add to Collection

Article Urology & Nephrology

Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

Alfred K. Cheung et al.

Summary: The updated KDIGO guideline on blood pressure management in chronic kidney disease emphasizes the importance of evidence-based recommendations, with a focus on blood pressure targets, antihypertensive medications, and specific management for kidney transplant recipients. The guideline also highlights the significance of proper blood pressure measurement protocols.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Review Critical Care Medicine

Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup

Josee Bouchard et al.

Summary: Beta-adrenergic antagonists (BAAs) poisoning can have serious consequences, but the utility of extracorporeal treatments (ECTRs) needs further investigation. Current research suggests that ECTRs may be feasible for certain poisoned patients with BAAs, but there is controversy regarding the use of ECTRs for other drugs in this class.

CRITICAL CARE (2021)

Add to Collection

Article Transplantation

β-blocker dialyzability and the risk of mortality and cardiovascular events in patients undergoing hemodialysis

Ping-Hsun Wu et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2020)

Add to Collection

Review Urology & Nephrology

Beta-blockers use from the general to the hemodialysis population

Mabel Aoun et al.

NEPHROLOGIE & THERAPEUTIQUE (2019)

Add to Collection

Article Urology & Nephrology

A Comparative Study of Carvedilol Versus Metoprolol Initiation and 1-Year Mortality Among Individuals Receiving Maintenance Hemodialysis

Magdalene M. Assimon et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Effectiveness comparison of cardio-selective to non-selective β-blockers and their association with mortality and morbidity in end-stage renal disease: a retrospective cohort study

Theresa I. Shireman et al.

BMC CARDIOVASCULAR DISORDERS (2016)

Add to Collection

Article Pharmacology & Pharmacy

Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers

Daniel V. Neves et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort

Chao-Hsiun Tang et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)

Add to Collection

Article Urology & Nephrology

β-Blocker Dialyzability and Mortality in Older Patients Receiving Hemodialysis

Matthew A. Weir et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)

Add to Collection

Article Urology & Nephrology

Excess mortality among patients on dialysis: Comparison with the general population in Korea

Hyungyun Choi et al.

KIDNEY RESEARCH AND CLINICAL PRACTICE (2014)

Add to Collection

Review Cardiac & Cardiovascular Systems

Meta-Analysis of Carvedilol Versus Beta 1 Selective Beta-Blockers (Atenolol, Bisoprolol, Metoprolol, and Nebivolol)

James J. DiNicolantonio et al.

AMERICAN JOURNAL OF CARDIOLOGY (2013)

Add to Collection

Review Cardiac & Cardiovascular Systems

Nebivolol:: A highly selective β1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide

Sandeep Gupta et al.

CARDIOVASCULAR THERAPEUTICS (2008)

Add to Collection

Article Urology & Nephrology

Nonselective beta-adrenergic blockade augments fasting hyperkalemia in hemodialysis patients

M Nowicki et al.

NEPHRON (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.